Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Coexistence of lymphoproliferative and myeloproliferative neoplasms with simultaneous CALR and JAK2 V617F mutations.

Cancer biomarkers : section A of Disease markers - 1 Jan 2016

Yang Hai-Su

Abstract excerpt

BACKGROUND: Hematopoietic malignancies are a group of blood cell disorders characterized by abnormal hematopoietic proliferation. OBJECTIVE: The identification of specific clinicopathologic characteristics and tumor-related gene status provides critical information on potential therapeutic targets. METHODS: The specimens were tested with immunohistochemistry, flow cytometry, RT-PCR and fragment analysis. RESULTS:...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Calreticulin
Share to CALR gene
Share to JAK2 gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Janus Kinase 2

Share to Lymphoproliferative Disorders

Share to Mutation

Share to Myeloproliferative Disorders

Source

Open in PubMed Open full text

Identifiers

PMID: 27662324
DOI: 10.3233/CBM-160652
PMCID: PMC13020521

Genes

CALR
JAK2

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Coexistence of lymphoproliferative and myeloproliferative neoplasms with simultaneous CALR and JAK2 V617F mutations.PMID 27662324Read ↗

A report on the co-occurrence of JAK2V617F and CALR mutations in myeloproliferative neoplasm patients.Semantic proximity Read ↗

Chronic lymphocytic leukemia and myeloproliferative neoplasms concurrently diagnosed: clinical and biological characteristics.Semantic proximity Read ↗

Presence of triple positive driver mutations in JAK2, CALR and MPL in primary myelofibrosis: a case report and literature review.Semantic proximity Read ↗

Coexisting driver mutations in MPN: clinical and molecular characteristics of a series of 11 patients.Semantic proximity Read ↗

Insights from a rare myeloproliferative neoplasm with coexisting BCR-ABL1 fusion gene, CALR and TET2 mutations treated with nilotinib and ruxolitinibSemantic proximity Read ↗

A Pedigree Analysis and Clonal Correlations of the Coexistence of B-Cell Lymphoma and Histiocytic/Dendritic Cell Tumor.Semantic proximity Read ↗

Emergence of MPLW515 mutation in a patient with CALR deletion: Evidence of secondary acquisition of MPL mutation in the CALR clone.Semantic proximity Read ↗

JAK2 V617F and CALR mutations are not mutually exclusive; findings from retrospective analysis of a small patient cohort.Semantic proximity Read ↗

The concomitant occurrence of JAK2V617F mutation and BCR/ABL transcript with phenotypic expression - an overlapping myeloproliferative disorder or two distinct diseases? - case report.Semantic proximity Read ↗

[Coexistence of mycosis fungoides and essential thrombocythemia with JAK2V617F].Semantic proximity Read ↗

Coexistence of renal cell carcinoma and malignant lymphoma. A causal relationship or coincidental occurrence?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.